Precipio
GenomOncology, Precipio Partner on Myeloid Test Reporting
GenomOncology's Pathology Workbench will be used as the clinical genomic reporting platform for Precipio's myeloid neoplasm test.
Precipio Receives CE-IVD Mark for Hematologic Cancer Panels
The company said it can now market its HemeScreen MPN, AML, Anemia/MDS, and CLL panels in the European Union and the UK.
In Brief This Week: Myriad Genetics, Diaceutics, Agios, Precipio, Lantern Pharma, Guardant Health
News items for the week of Jan. 18, 2021.
Results from a recent study clarify some conflicting prior determinations, and provide a new rationale to further explore the FCGR2A biomarker in prospective trials.